BDBM72347 1-[(4-chlorobenzylidene)amino]-3-(2-furfuryl)thiourea::1-[(4-chlorophenyl)methylideneamino]-3-(2-furanylmethyl)thiourea::1-[(4-chlorophenyl)methylideneamino]-3-(furan-2-ylmethyl)thiourea::4-chlorobenzaldehyde N-(2-furylmethyl)thiosemicarbazone::MLS000701371::SMR000225230::cid_696660

SMILES Clc1ccc(C=NNC(=S)NCc2ccco2)cc1

InChI Key InChIKey=KPERVOSZAUQBFM-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72347   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72347BDBM72347(9-Chloro-2,3,8-trifluoro-10,11,12,13-tetrahydro-19...)
Affinity DataIC50: 6.31nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent